glp-1 and celiac disease Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism Celiac Disease, Semiglutide and Gut

Starting at a low dose and titrating gradually minimizes intolerance

It really is a non-negotiable

Side effects are not the only concern

The bottom line Berberine and GLP-1 medicines are often talked about in the same breath, but they are not the same thing and were never meant to be

RO, QW, and HS contributed to writing and editing of the manuscript

Cagrilintide also has one of the lowest GI odds ratios among the incretin and amylin compound class in a 2025 Bayesian network meta-analysis of multi-target obesity therapies the relevance for the stack is that adding cagrilintide to retatrutide may not compound GI burden as severely as adding a second GLP-1 agonist would